Analyst upgrades, downgrades and initiations: LSI, ESI, UBS, CS JBHT ...


Analyst upgrades:
  • Friedman Billings upgraded LSI Corp (NYSE: LSI) to Outperform from Market Perform as it believes the risk/reward is attractive at current levels as the company's near-term business trends are stabilizing. The firm maintains a $4 target on the stock.
  • Merriman upgraded shares of Medarex (NASDAQ: MEDX) to Neutral from Sell on valuation following the stock's 40% decline year-to-date.
  • Morgan Stanley upgraded ITT Educational (NYSE: ESI) to Overweight from Equal Weight. The firm believes valuation appropriately discounts risks from its internal lending program.
  • Noble (NYSE: NE) was upgraded to Buy from Neutral at Goldman and added to the Conviction Buy List.
  • Energizer (NYSE: ENR) was raised to Neutral from Sell at UBS.
  • Arch Chemicals (NYSE: ARJ) was upgraded at KeyBanc to Hold from Underweight.
Analyst downgrades:
  • Citigroup downgraded shares of Genzyme (NASDAQ: GENZ) to Hold from Buy to reflect a lack of visibility for the timeline of Lumizyme's approval. The firm lowered its target price to $61 from $81.
  • Bernstein downgraded shares of UBS (NYSE: UBS) and Credit Suisse (NYSE: CS) to Underperform from Market Perform as it believes the outlook for private wealth management remains weak.
  • RBC Capital downgraded Max Capital (NASDAQ: MXGL) to Sector Perform from Outperform and lowered its target to $18 from $21 following the merger announcement with IPC Holdings (NASDAQ: IPCR). Note that the firm downgraded IPCR to Sector Perform from Outperform.
  • Career Education (NASDAQ: CECO) was cut to Underweight from Equal Weight at Morgan Stanley.
  • Royal Bank of Scotland (NYSE: RBS) was lowered to Sell from Nuetral at WestLB.
  • D.R. Horton (NYSE: DHI) was downgraded to Underperform from Neutral at Credit Suisse.
Analyst initiations:
  • Jefferies initiated Qiagen (NASDAQ: QGEN) with a Buy rating and $20 target and believes the company's exposure to the molecular diagnostics market will drive double-digit sales and EPS growth.
  • Suntrust initiated Bob Evans (NASDAQ: BOBE) with a Neutral rating citing Mimi's Cafe underperformance and exposure to states with large numbers of foreclosures and unemployment.
  • Baird believes near-term expectations for Quanta Services (NYSE: PWR) may be too high. Shares were started with a Neutral rating and $19 target.
  • FPL Group (NYSE: FPL) was assumed with a Buy rating and $55 target at Soleil.
  • Lamar Advertising (NASDAQ: LAMR) was initiated with an Overweight rating and $30 target at Morgan Stanley.
    J.B. Hunt (NASDAQ: JBHT) was initiated at BMO Capital with a Market Perform rating.
Symbol Lookup
IndexesChangePrice
DJIA-89.2312,801.23
NASDAQ-23.352,903.88
S&P 500-9.311,342.64

Last updated: February 13, 2012: 07:52 AM

Hot Stocks

General Electric

18.875-0.255(-1.33)

Alcoa

10.29-0.35(-3.29)

Apple Inc

493.42+0.25(+0.05)

Google Inc 'A'

605.91-5.55(-0.91)

Bank of America

8.07-0.11(-1.34)

Wal-Mart Stores

61.90-0.06(-0.10)

Exxon Mobil Corp

83.80-1.08(-1.27)

Ford

12.44-0.25(-1.97)

Citigroup

32.925-0.735(-2.18)

IBM

192.42-0.71(-0.37)

Yahoo

16.14+0.14(+0.88)

Starbucks

48.82-0.38(-0.77)

Microsoft

30.495-0.275(-0.89)

Home Depot

45.33+0.06(+0.13)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1329137570078 ms.